Table 2.
Group | n | Liver CD44 mRNA, × 107/per mg tissues | Liver AFP mRNA, × 108/per mg tissues |
Control | 12 | 1.844 ± 0.305 | 4.859 ± 0.636 |
NAFLD | 24 | 2.234 ± 0.441 | 4.150 ± 0.439 |
Denaturation | 17 | 3.008 ± 0.436a | 5.575 ± 1.672 |
Precancerosis | 15 | 2.942 ± 0.530a | 6.749 ± 0.949a |
HCC | 10 | 3.593 ±1.554a | 5.731 ± 0.404a |
P < 0.05 vs control group. AFP: Alpha-fetoprotein; HCC: Hepatocellular carcinoma; NAFLD: Nonalcoholic fatty liver disease.